Skip to main content

Havrix 1440 Adult

Product overview

Type
Hepatitis A (Human Diploid Cell), Inactivated (Adult)
Commercial Name
Havrix 1440 Adult
Manufacturer
GlaxoSmithKline Biologicals SA
Responsible NRA
Federal Agency for Medicines and Health Products
Country
Belgium

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
a.Carton of 100 vials [Dimensions 17.8x14.7x3.7 cm]; b.Carton of 25 vials [Dimensions 9.9x7.7x3.7] cm; c.Carton of 10 vials [Dimensions 8.4x3.7x3.7 cm; d.Carton of 1 vial [Dimensions 3.1x3.1x 6.0 cm]
Tertiary Packaging
Insulated Shipping box [Dimensions 34x25x43 cm] of: 24 cartons of 100 vials (2400 doses); 96 cartons of 25 vials (2400 doses); 240 cartons of 10 vials (2400 doses); 420 cartons of 1 vial (420 doses)
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
a)9.6; b)11.3 ; c)11.5; d)57.7 cm3/dose (in secondary packaging)

Attachments

Container Photo
VPSAR (Vaccine Public Summary Assessment Report)
Package Insert